http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0113330-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c4b5de903f1f1a48d94e33c0cd2e136e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C235-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195
filingDate 1983-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_176c5b7803048c303277fdf1dd47a5e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b70b449a5ef589ef5a607888f384cbc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae19142d84b2ae1c838f6902757a8d90
publicationDate 1984-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0113330-A1
titleOfInvention Acylated enamide compounds, pharmaceutical compositions containing them and use of these compounds
abstract - Z représente un groupement donneur d'électrons; - vaut 1, 2 ou 3; - R' représente l'hydrogène, un halogène ou un groupement organique quelconque, ou des sels, complexes, dérivés alkylés ou dérivés acylés de ces composés. The acylated enamide compounds are acylated enamides corresponding to the general formula: in which - Z represents an electron donor group; - is 1, 2 or 3; - R 'represents hydrogen, a halogen or any organic group, or salts, complexes, alkyl derivatives or acyl derivatives of these compounds. n n n Typical acylated enamide compounds according to the invention correspond to the formula: n n n These acylated enamide compounds and the pharmaceutical compositions containing them can be used for the prevention and treatment of cancers.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5871755-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0219344-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0706995-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4793949-A
priorityDate 1982-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2449191-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-2201478-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4112
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57272424
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129362157
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395835
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136092942
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135898261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4211
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID126941
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91452
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396111
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2336
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127868578
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88635215
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135444779
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID30323
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397441
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443939
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136238575
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57417070
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226424860
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128866030
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396332
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66577526
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395318
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6058
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135789409
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6253
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID460612
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70400366
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2708
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396360
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128255004
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128663625
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6603772
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396384
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396110
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235869707
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394280
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395395
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235866371
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129803828
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395394
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395949
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136304789
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395470
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9991
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2478

Total number of triples: 87.